Alameda, CA · Founded 2020 · Privately Held (backing)
Operator of a biotechnology company intended to develop precision immunology for autoimmune diseases. Santa Ana Bio is based in Alameda, CA and was founded in 2020. Its last known valuation is $270 million. It has raised $203 million across 3 recorded rounds; the latest was a $20 million early-stage round in May 2024.
Last price · $/share
—
Implied valuation
$270.0M
Total raised
$203.0M
Last round
Early Stage VC
May 2024
Cap table — not yet on record
Santa Ana Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Santa Ana Bio with a free account
·Watch Santa Ana Bio: the Monday email on marks, rounds and moves
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Santa Ana Bio's 3 recorded funding rounds.
